GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $43,300,000 | +97.2% | 1,250,000 | +66.7% | 5.61% | +148.0% |
| Q4 2021 | $21,953,000 | -53.2% | 750,000 | -11.8% | 2.26% | -62.3% |
| Q3 2020 | $46,869,000 | +449.9% | 850,000 | +529.6% | 6.00% | +252.2% |
| Q2 2020 | $8,523,000 | -10.3% | 135,000 | -27.4% | 1.70% | -52.9% |
| Q1 2020 | $9,499,000 | – | 185,933 | – | 3.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |